Ullman Anders

CIK 00018368161 companyLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001836816

Recent Transactions

17 trades

Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07−72,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−200,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−72,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−64,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−358,856→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−96,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−240,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07+72,000→ 72,000 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01+24,000→ 358,856 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Stock Units
2025-08-01−24,000→ 72,000 total
Award
Verona Pharma plc$VRNA
Restricted Share Units
2025-04-25+96,000→ 96,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2024-04-29+240,000→ 240,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2023-04-28+96,000→ 96,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2022-04-28+200,000→ 200,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2021-08-09+64,000→ 64,000 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2021-05-04$0.84/sh−12,056→ 334,856 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2021-02-01$0.99/sh−10,800→ 346,912 total

Companies

Verona Pharma plc
Director
$VRNA

Recent Filings

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE

View on SEC.gov